Send the following on WhatsApp
Continue to Chathttps://es.marketscreener.com/cotizacion/accion/ADDEX-THERAPEUTICS-LTD-261774/noticia/Addex-Therapeutics-Ltd-anuncia-que-se-espera-que-el-estudio-de-epilepsia-de-fase-2-ADX71149-arroje-d-44808912/?utm_source=whatsapp&utm_medium=social&utm_campaign=share